GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R307. A total of 5 filers reported holding GENETIC TECHNOLOGIES LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $0 | – | 500 | -70.6% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 1,700 | -90.5% | 0.00% | -100.0% |
Q1 2021 | $39,000 | +77.3% | 17,900 | -7.0% | 0.00% | +100.0% |
Q4 2020 | $22,000 | +2100.0% | 19,253 | +1981.4% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 925 | +12.1% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 825 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 825 | -37.7% | 0.00% | – |
Q4 2019 | $2,000 | 0.0% | 1,325 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | – | 1,325 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Scarborough Advisors, LLC | 10,638 | $8,113 | 0.00% |
RHUMBLINE ADVISERS | 18,700 | $14,378 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MORGAN STANLEY | 87,656 | $66,846 | 0.00% |
TWO SIGMA SECURITIES, LLC | 15,844 | $12,083 | 0.00% |